ABIOMED, Inc. ABMD Income Statement

Abiomed, inc. (ABMD)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10
Product revenue
-	-	-	-	-	-	-	-	-	-	132,782	132,431	124,654	114,624	102,928	102,989	93,951	85,789	76,354	73,426	67,550	61,966	51,774	48,660	50,242	46,141	44,288	42,609	43,536	38,112	37,319	38,647	37,237	31,732	29,151	27,166	28,103	26,915	23,058	21,761
Funded research and development
-	-	-	-	-	-	-	-	-	-	41	37	26	50	27	6	6	6	5	6	7	39	164	151	191	54	57	61	138	138	98	136	107	466	327	189	426	329	318	241
Revenue
206,658	221,584	204,974	207,666	207,081	200,563	181,778	180,010	174,436	154,022	132,823	132,468	124,680	114,674	102,955	102,995	93,957	85,795	76,359	73,432	67,557	62,005	51,938	48,811	50,433	46,195	44,345	42,670	43,674	38,250	37,417	38,783	37,344	32,198	29,478	27,355	28,529	27,244	23,376	22,002
Costs and expenses:
Cost of revenue
39,369	39,996	34,867	37,073	34,848	34,023	29,846	30,850	30,098	24,994	21,627	21,862	19,261	18,987	17,309	15,070	14,663	12,744	12,144	10,868	10,806	9,838	9,612	9,689	10,114	9,458	9,027	8,723	8,826	8,130	7,194	7,446	6,786	6,279	5,551	5,891	5,848	5,437	5,408	5,284
Research and development
25,345	25,655	23,969	23,790	25,548	23,965	22,717	21,273	21,270	17,706	19,390	16,931	16,325	16,349	18,052	15,660	14,225	13,755	11,569	10,210	9,853	8,365	8,693	9,062	7,920	7,779	7,721	7,287	6,822	6,259	5,854	6,712	7,236	6,140	6,459	7,324	6,843	6,592	6,589	6,653
Selling, general and administrative
83,892	85,674	85,956	86,078	81,296	80,220	78,895	81,139	75,501	66,556	60,080	60,597	60,100	53,935	53,086	51,032	45,256	41,853	39,829	37,323	34,535	30,139	29,455	31,598	28,721	24,364	26,199	27,967	23,894	20,943	18,437	20,953	20,028	17,184	16,323	18,176	16,888	15,592	14,054	15,753
Amortization of intangible assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	111	352	362	379	385	361	295	372	367
Costs and Expenses, Total
148,606	151,325	144,792	146,941	141,692	138,208	131,458	133,262	126,869	109,256	101,097	99,390	95,686	89,271	88,447	81,762	74,144	68,352	63,542	58,401	55,194	48,342	47,760	50,349	46,755	41,601	42,947	43,977	39,542	35,332	31,485	35,222	34,402	29,965	28,712	31,776	29,940	27,916	26,423	28,057
Income from operations
58,053	70,259	60,182	60,725	65,389	62,355	50,320	46,748	47,567	44,766	31,726	33,078	28,994	25,403	14,508	21,233	19,813	17,443	12,817	15,031	12,363	13,663	4,178	-1,538	3,678	4,594	1,398	-1,307	4,132	2,918	5,932	3,561	2,942	2,233	766	-4,421	-1,411	-672	-3,047	-6,055
Other income:
Investment income, net
3,100	3,086	2,932	3,049	2,769	2,175	1,671	1,551	1,303	969	781	635	486	457	342	269	186	84	62	63	68	48	36	44	40	37	25	16	-7	1	1	-2	1	-2	-6	4	8	4	-1	-2
Other (expense) income, net
-21,840	23,671	-45,756	39,364	30,372	-20	-158	188	-363	-81	-23	79	-124	-34	-114	-77	228	-29	87	53	-59	-10	-39	11	44	20	6	-21	15	324	-9	-4	-15	39	66	-81	-126	30	-128	81
Gain on sale of WorldHeart stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	217	239
Gain on settlement of investment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,017	-	-	-	-	-	-
Nonoperating Income (Expense), Total
-18,739	26,757	-42,824	42,413	33,141	2,155	1,513	1,739	940	888	758	714	362	423	228	192	414	55	149	116	9	38	-3	55	84	57	31	-5	8	325	-8	-6	-14	1,054	60	-77	-118	34	88	318
Income before income taxes
39,313	97,016	17,358	103,138	98,530	64,510	51,833	48,487	48,507	45,654	32,484	33,792	29,356	25,826	14,736	21,425	20,227	17,498	12,966	15,147	12,372	13,701	4,175	-1,483	3,762	4,651	1,429	-1,312	4,140	3,243	5,924	3,555	2,928	3,287	826	-4,498	-1,529	-638	-2,959	-5,737
Income tax provision
7,515	27,800	4,300	14,200	24,569	19,600	1,700	-41,600	11,660	32,208	7,981	-3,582	14,457	10,394	5,861	8,515	9,229	6,943	5,231	6,288	-86,502	1,017	336	226	140	258	370	411	398	559	455	436	361	366	225	96	243	164	242	243
Net income
31,798	69,217	13,071	88,923	73,961	44,862	50,127	90,066	36,847	13,446	24,503	37,374	14,899	15,432	8,875	12,910	10,998	10,555	7,735	8,859	98,874	12,684	3,839	-1,709	3,622	4,393	1,059	-1,723	3,742	2,684	5,469	3,119	2,567	2,921	601	-4,594	-1,772	-802	-3,201	-5,980
Basic net income per share
0.71	1.53	0.29	1.97	1.64	1.00	1.11	2.02	0.83	0.30	0.56	0.85	0.34	0.36	0.21	0.30	0.26	0.25	0.18	0.21	2.44	0.31	0.09	-0.04	0.09	0.11	0.03	-0.04	0.09	0.07	0.14	0.08	0.06	0.08	0.02	-0.12	-	-0.02	-0.09	-
Basic weighted average shares outstanding
45,042	45,140	45,319	45,215	45,091	45,046	44,961	44,546	44,329	44,247	44,141	43,895	43,581	43,431	43,129	42,811	42,465	42,427	42,228	41,696	41,162	40,856	40,448	40,062	39,806	39,592	39,260	38,678	38,460	39,417	39,431	39,144	38,474	38,498	38,256	38,268	-	37,195	37,156	-
Diluted net income per share
0.70	1.51	0.28	1.93	1.60	0.97	1.09	1.95	0.80	0.29	0.54	0.82	0.34	0.34	0.20	0.29	0.25	0.23	0.17	0.20	2.30	0.30	0.09	-0.04	0.08	0.11	0.03	-0.04	0.09	0.07	0.13	0.08	0.07	0.07	0.02	-0.12	-	-0.02	-0.09	-
Diluted weighted average shares outstanding
45,565	45,695	45,912	46,092	46,146	46,136	46,153	46,169	46,221	45,869	45,698	45,608	44,104	44,770	44,580	45,178	45,299	44,949	44,922	44,410	46,247	42,884	42,239	40,062	44,683	41,726	41,337	38,678	40,072	40,865	41,722	41,549	42,784	40,270	39,366	38,268	-	37,195	37,156	-
Basic and diluted net loss per share
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.16
Weighted average shares outstanding
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	37,086